PTSD Trial, Recruiting (NCT07652645)

PTSD Trial, Recruiting NCT07652645 Sponsor: Arkin Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT07652645 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult (18 years or older) who has served in the military and is being treated at Sinai Center
You have some knowledge of DBT (Dialectical Behaviour Therapy)
Your main diagnosis is PTSD caused by war-related experiences, confirmed through a specific assessment called the CAPS-5
You have been on the same medication at the same doses for at least four weeks
You are able to complete homework assignments online and communicate with your therapist through a digital health platform
You speak Dutch

Who may not be able to join:

You have been diagnosed with chronic psychosis (though psychosis as a side effect of PTSD may still be allowed — confirm with trial site) or bipolar disorder type 1
You have an IQ below 80 or have been diagnosed with a cognitive disorder
Your main problem is severe self-harm, such as self-mutilation, or you are currently experiencing suicidal thoughts as your primary concern
You are currently receiving day treatment or another intensive treatment programme for ongoing symptoms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07652645

Sponsor: Arkin

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

More information: https://clinicaltrials.gov/study/NCT07652645

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult (18 years or older) who has served in the military and is being treated at Sinai Center
You have some knowledge of DBT (Dialectical Behaviour Therapy)
Your main diagnosis is PTSD caused by war-related experiences, confirmed through a specific assessment called the CAPS-5
You have been on the same medication at the same doses for at least four weeks
You are able to complete homework assignments online and communicate with your therapist through a digital health platform
You speak Dutch

Who may not be able to join:

You have been diagnosed with chronic psychosis (though psychosis as a side effect of PTSD may still be allowed — confirm with trial site) or bipolar disorder type 1
You have an IQ below 80 or have been diagnosed with a cognitive disorder
Your main problem is severe self-harm, such as self-mutilation, or you are currently experiencing suicidal thoughts as your primary concern
You are currently receiving day treatment or another intensive treatment programme for ongoing symptoms

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Arkin

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

1 September 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

PTSD Checklist for the DSM-5 (PCL-5); Difficulties in Emotion Regulation Scale Short Form (DERS-SF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov